"Top 5" lists top $5 billion

Archives of Internal Medicine

Volumn 171, Issue 20, 2011, Pages 1856-1858

  Kale, Minal S ^a   Bishop, Tara F ^b   Federman, Alex D ^a   Keyhani, Salomeh ^c,d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; GENERIC DRUG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ROSUVASTATIN;

AMBULATORY CARE; ASTHMA; BLOOD CELL COUNT; BONE SCINTISCANNING; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DRUG COST; DUAL ENERGY X RAY ABSORPTIOMETRY; ELECTROCARDIOGRAPHY; FEMALE; HEALTH CARE; HEALTH CARE COST; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; OTITIS MEDIA; PAPANICOLAOU TEST; PRESCRIPTION; PRIORITY JOURNAL; RADIOGRAPHY;

AMBULATORY CARE; COST SAVINGS; EPISODE OF CARE; HEALTH SERVICES MISUSE; HUMANS; PHYSICIANS, PRIMARY CARE; UNITED STATES; UNNECESSARY PROCEDURES;

EID: 81355133388     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2011.501     Document Type: Note

References (5)

1. The Good Stewardship Working Group. The "top 5" lists in primary care: meeting the responsibility of professionalism. Arch Intern Med. 2011;171(15): 1385-1390.
2. Centers for Disease Control and Prevention. NAMCS scope and design. http: //www.cdc.gov/nchs/ahcd/ahcd-scope.htm#namcs-scope. Accessed July 29, 2011.
3. Centers for Medicare and Medicaid Services. CMS files for download for Medicare. http://www.cms.gov/ClinicalLabFeeSched/02-clinlab .asp#TopOfPage. Accessed on July 27, 2011.
4. Choudhry NK, Avorn J, Antman EM, Schneeweiss S, Shrank WH. Should patients receive secondary prevention medications for free after a myocardial infarction? an economic analysis. Health Aff (Millwood). 2007;26(1):186-194.
5. Lazar LD, Pletcher MJ, Coxson PG, Bibbins-Domingo K, Goldman L. Cost-effectiveness of statin therapy for primary prevention in a low-cost statin era. Circulation. 2011;124(2):146-153.